AML/MDS
Clinical trials for AML/MDS explained in plain language.
Never miss a new study
Get alerted when new AML/MDS trials appear
Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo targets tough blood cancers
Disease control Recruiting nowThis early-stage study tests a new drug called danvatirsen, first alone and then combined with venetoclax, in adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that have come back or not responded to standard treatments. The goal is to see if the treatme…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Engineered immune cells take aim at childhood leukemias in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T-cell therapy for children and young adults (up to age 21) with certain blood cancers that have come back or not responded to standard treatment. The therapy uses the patient's own or a donor's immune cells, which are…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC